Co-Diagnostics, Inc. to host booth at AACC held July 24-28 in Chicago
The Company will also be providing an update to its distributors and other customers on July 26 at 11 am CT
20 Jul 2022
Co-Diagnostics, Inc. (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, has announced that it will be hosting a booth to showcase its existing and upcoming suite of diagnostics products and technology applications at the 2022 AACC Annual Scientific Meeting & Clinical Lab Expo, held July 24-28 at the McCormick Place Convention Center in Chicago, IL, in addition to providing an update for its worldwide network of customers and distributors.
Current and potential Co-Dx™ distributors, customers, and partners are invited to join the Company in room S103A at 11:00 AM CT for the Co-Dx global customer and distributor update. Over the past few years, Co-Dx has established a broad and growing distribution network that has sold over 34,000,000 PCR tests in over 50 countries.
On Tuesday at 2:00 pm CT, Company CEO Dwight Egan will also be conducting a presentation at the Company's booth on the Co-Dx PCR Home testing platform and introducing Dr. Kirk Ririe and Dr. Carl Wittwer, pioneers of rapid and real-time PCR, key personnel in the platform's development, and respectively president of the Company's wholly owned subsidiary and Chairman of the Company's Scientific Advisory Board.
Co-Diagnostics invites all interested parties to booth #2878, as well as to the Company's kiosk displaying our forthcoming Co-Dx PCR Home testing platform in the Disruptive Technologies Pavilion following Co-Dx being named a semifinalist in the 2022 AACC Disruptive Technology Award Competition.
To learn more about the conference, including registration and exhibitor details, please visit https://meeting.aacc.org.
The Co-Dx PCR Home testing platform device is subject to FDA review and is not available for sale.